NNMT is over-expressed in fat and liver tissue in obese, diabetic animals, and genetic knockdown of NNMT protects mice against diet-induced obesity by increasing energy expenditure
It is studied in tissue-repair, angiogenesis, and gastrointestinal research models and is offered strictly as a research-use-only catalog material for laboratory use only
Always consult your personal gastroenterologist before starting or altering any treatment protocol
A review discussing BPC 157 as a potential treatment for COVID-19 echoes similar issues with available data surrounding BPC 157, but does note that BPC 157 has been proven to be efficacious and safe in clinical trials evaluating its use for inflammatory bowel disease (mild to moderate ulcerative colitis)
Do these daily once the acute pain fades
Although some healthcare providers may consider BPC-157 in carefully selected situations, more high-quality human research is still needed to better understand its safety and effectiveness